IOVA compared with LION: revenue, margins and what each company keeps, and the suppliers and customers both name

IOVAIovance Biotherapeutics, Inc.

Mkt capRevenueRevenue

LIONLionsgate Studios Corp.

Mkt capRevenueRevenue

Compare

IOVAIovance Biotherapeutics, Inc.

LIONLionsgate Studios Corp.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IOVA 12

NVSNovartis Pharmasupplier

—Boehringer Ingelheim Biopharmaceuticals GmbHunlistedsupplier

—National Cancer Institute (NCI)unlistedsupplier

—National Institutes of Health (NIH)unlistedsupplier

8 more · IOVA chain ›

Shared 0

No shared counterparties.

Only LION 7

AMZNAmazon.comcustomer

—Directors Guild of Americaunlistedsupplier

—Screen Actors Guild - American Federation of Television and Radio Artistsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Writers Guild of America

unlistedsupplier

3 more · LION chain ›

IOVAIovance Biotherapeutics, Inc.

8.38▲+4.43%

Mkt cap$3.6BRevenue$99MQ2 FY26Revenue$264MFY25

LIONLionsgate Studios Corp.

12.23▲+0.73%

Regular sessionNov 3 '26

Mkt cap$3.5BRevenue$777MQ1 FY27Revenue—

Compare

Regular sessionNov 3 '26

IOVAIovance Biotherapeutics, Inc.

LIONLionsgate Studios Corp.

8.38▲+4.43%

Price

12.23▲+0.73%

$3.6B

Mkt cap

$3.5B

Q2 FY26$99M

Revenue

$777MQ1 FY27

FY25$264M

Revenue

—

IOVA8.38▲+4.43%vsLION12.23▲+0.73%Regular sessionNov 3 '26